Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma

Introduction: This study aimed to identify immune mediators, including cytokines, chemokines, and growth factors, in the plasma for predicting treatment efficacy and immune-related adverse events (irAEs) in advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs). Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Yosuke, Kishida, Takeshi, Kouro, Taku, Wei, Feifei, Igarashi, Yuka, Himuro, Hidetomo, Noguchi, Takeaki, Koizumi, Mitsuyuki, Suzuki, Takahisa, Osaka, Kimito, Saigusa, Yusuke, Sasada, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679331/
https://www.ncbi.nlm.nih.gov/pubmed/38026978
http://dx.doi.org/10.3389/fphar.2023.1269935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679331/
https://www.ncbi.nlm.nih.gov/pubmed/38026978
http://dx.doi.org/10.3389/fphar.2023.1269935

Ejemplares similares